Clinical Trial

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

Name: Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC) — clinical trial record (NCT07762586)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a two-arm phase II randomized trial investigating patients with luminal subtype muscle-invasive bladder cancer (MIBC) receiving neoadjuvant therapy (NAT) followed by cystectomy compared to those receiving upfront cystectomy.

Trial Details

NCT Number	NCT07762586
Lead Sponsor	Rutgers, The State University of New Jersey
Conditions	Bladder Cancer
Enrollment	60 participants
Start Date	2026-07-10
Primary Completion	2027-07 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-13